China Money Network
Login
Join

China’s HG Capital Leads $23M Round In Nuokangda Pharmaceutical

  • February 14, 2017 — 12:24 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese private equity firm HG Capital has invested RMB160 million (US$23 million) in Beijing Nuokangda Pharmaceutical Technology Co., Ltd, a contract research organization focused on... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: